Legal & General Group’s Lyell Immunopharma LYEL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,005
| Closed | -$8.07K | – | 3486 |
|
|
2025
Q1 | $8.07K | Hold |
15,005
| – | – | ﹤0.01% | 3216 |
|
|
2024
Q4 | $9.6K | Sell |
15,005
-101,392
| -87% | -$64.9K | ﹤0.01% | 3260 |
|
|
2024
Q3 | $160K | Hold |
116,397
| – | – | ﹤0.01% | 2698 |
|
|
2024
Q2 | $168K | Sell |
116,397
-7,130
| -6% | -$10.3K | ﹤0.01% | 2686 |
|
|
2024
Q1 | $275K | Buy |
123,527
+2,362
| +2% | +$5.27K | ﹤0.01% | 2625 |
|
|
2023
Q4 | $235K | Hold |
121,165
| – | – | ﹤0.01% | 2673 |
|
|
2023
Q3 | $178K | Buy |
121,165
+9,392
| +8% | +$13.8K | ﹤0.01% | 2743 |
|
|
2023
Q2 | $355K | Buy |
111,773
+95,724
| +596% | +$304K | ﹤0.01% | 2570 |
|
|
2023
Q1 | $37.6K | Hold |
16,049
| – | – | ﹤0.01% | 2922 |
|
|
2022
Q4 | $55.8K | Hold |
16,049
| – | – | ﹤0.01% | 2937 |
|
|
2022
Q3 | $117K | Buy |
16,049
+1,423
| +10% | +$10.4K | ﹤0.01% | 2773 |
|
|
2022
Q2 | $95K | Buy |
14,626
+439
| +3% | +$2.85K | ﹤0.01% | 2868 |
|
|
2022
Q1 | $72K | Buy |
14,187
+11,991
| +546% | +$60.9K | ﹤0.01% | 2934 |
|
|
2021
Q4 | $17K | Hold |
2,196
| – | – | ﹤0.01% | 3327 |
|
|
2021
Q3 | $33K | Buy |
2,196
+1,720
| +361% | +$25.8K | ﹤0.01% | 3093 |
|
|
2021
Q2 | $8K | Buy |
+476
| New | +$8K | ﹤0.01% | 3438 |
|